Showing results (361-370 of 1,757) with videos related to
Sort By:
Pageof 176
Progress in Cardiovascular Diseases|August 20, 2025
Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future directionsJonathan D Knott, Ellen Kronzer, Nandan Anavekar, et al.Progress in Cardiovascular Diseases|August 21, 2025
Fabry disease cardiomyopathy: A state-of-the-art reviewShivangi Pande, Fahimeh Varzideh, Jessica Gambardella, et al.Progress in Cardiovascular Diseases|February 27, 2023
Assessment of lifestyle "vital signs" in healthcare settingsAlan Rozanski, Sakul Sakul, Jagat Narula, et al.Progress in Cardiovascular Diseases|November 18, 2022
Clinical conundrums involving statin drug-drug interactionsDonald G Lamprecht, Joseph J Saseen, Paul B ShawProgress in Cardiovascular Diseases|December 11, 2025
Evaluation of the PREVENT risk assessment tool and visceral adiposity: Insights from the UK BiobankPamela L Alebna, Mathew Ambrosio, Rohan Dod, et al.Progress in Cardiovascular Diseases|August 26, 1998
The sympathetic nervous system in chronic heart failureJ Joseph, E M GilbertProgress in Cardiovascular Diseases|August 26, 1998
Use of carvedilol in chronic heart failure: challenges in therapeutic managementJ D Sackner-BernsteinProgress in Cardiovascular Diseases|August 26, 1998
The cardiac toxicity of anabolic steroidsM L Sullivan, C M Martinez, P Gennis, et al.Progress in Cardiovascular Diseases|August 26, 1998
The extracellular matrix in balloon arterial injury: a novel target for restenosis preventionW B Batchelor, R Robinson, B H StraussProgress in Cardiovascular Diseases|August 26, 1998
Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction TrialS M Jafri, S Borzak, J Goldberger, et al.Pageof 176